Leader in the “Eyes” of Embodied Intelligence: Initiating Coverage with Overweight, Target Price Rmb150

Overview

The report positions Orbbec as a leading 3D machine vision platform in the embodied intelligence and humanoid robot value chain. Leveraging full-stack technology reserves, self-developed chips, manufacturing and quality control capabilities, as well as deep partnerships with NVIDIA, Microsoft, and leading domestic robot manufacturers, the company has built relatively high switching costs. As humanoid robots transition from prototypes to scaled deployment, the company is expected to benefit from the dual drivers of shipment growth and increased vision value per unit, while overseas and domestic capacity expansion will support growth in businesses beyond robotics.

Core views

The core thesis consists of four points: first, the company has an estimated approximately 95% share, according to management, in China’s humanoid robot vision hardware market, with platform compatibility, reliability, and customer trust forming its moat; second, scaling global humanoid robot volumes will significantly expand demand for 3D vision, and China’s supply chain is in a leading position in near-term commercialization; third, higher levels of robot intelligence will increase the number of vision modules and support higher value per unit and gross margin; fourth, AIoT, general robotics, and 3D scanning businesses provide additional growth sources, while capacity expansion and scale effects are expected to bring operating leverage.

Analysis framework

The report combines company and management data, JPMorgan forecasts, industry chain research, and comparable company valuation analysis. Near-term humanoid robot shipment forecasts are based on bottom-up channel checks with OEMs, component suppliers, and distributors, while long-term forecasts reference labor shortages, the penetration curves of smartphones and new energy vehicles, and progress in embodied intelligence technologies; valuation uses expected FY2027 price-to-sales ratio and is cross-validated through comparable companies, margins, market share, and risk thresholds.

Methodology notes

• Valuation methodForward price-to-sales valuation

  Determining the target price based on expected FY2027 sales and a 23x price-to-sales ratio

  Given that the humanoid robot industry remains in the early stage of commercialization, R&D investment is high, and revenue growth is the primary value driver, the report uses a price-to-sales methodology rather than a valuation method centered on current earnings, deriving a December 2027 target price of Rmb150.

• Industry forecastBottom-up shipment forecast

  Forecasting humanoid robot shipments based on industry chain research

  Forecasts for 2026–2027 are mainly based on channel checks with OEMs, component suppliers, and distributors, while long-term forecasts further incorporate labor shortages, technology maturity, and historical product penetration curves.

• Fundamental analysisVolume-price and value-per-unit framework

  Combining robot shipment growth, the number of modules per unit, and single-module pricing

  The report examines not only volume growth in robot shipments, but also the possibility that vision modules increase from 1–2 per unit to at least 4 and even 6–10, in order to assess revenue elasticity and gross margin potential.

• Competitive analysisPlatform moat and ecosystem stickiness analysis

  Assessing competitive advantages from technology breadth, chip R&D, manufacturing capabilities, platform compatibility, and customer relationships

  The company covers multiple 3D vision technology routes and is embedded in platforms such as NVIDIA Isaac, Microsoft, Intel, and OpenHarmony, forming a one-stop solution and relatively high switching costs.

• Risk managementKey threshold monitoring

  Using market share and gross margin as warning indicators for the investment thesis

  The report believes that if the company’s share in China’s humanoid robot application market falls below 80% within three years, or if gross margin falls below 40% due to price competition or technological substitution, the investment thesis would face a meaningful challenge.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Orbbec (688322.SS)

  Core covered company and proxy for China’s humanoid robot 3D vision value chain

  Strengths

  Management estimates approximately 95% domestic market share; covers mainstream 3D vision routes; has self-developed chips, manufacturing capabilities, and platform ecosystem partnerships; high robotics business exposure and potential to increase value per unit.

  Weaknesses

  Short listed-company history, high valuation, significant share price volatility, and pressure from capacity expansion, quality control, working capital, and commercialization delivery.

  Comparison

  Compared with integrated sensor manufacturers, the company is more focused on 3D vision; the report believes its valuation can be positioned at the upper end of the comparable company range.

  Risks

  Competitor design wins, software vision substitution, fewer modules than expected, declines in market share and gross margin, and delays in humanoid robot volume growth.

• Leader Drive (688187 CH)

  The closest A-share comparable company among core humanoid robot components

  Strengths

  Has a core component position in the humanoid robot value chain, high entry barriers, and similar margins, and benefits from domestic OEM shipment growth.

  Weaknesses

  The business is not a 3D vision platform, and its value drivers differ from Orbbec’s.

  Comparison

  Like Orbbec, it is a high-barrier robotics component supplier and also has relatively high humanoid robot revenue exposure.

  Risks

  Industry shipments falling short of expectations, intensifying competition, and valuation volatility.

• Hesai and RoboSense

  Comparable companies in broad machine vision sensors and potential competitors

  Strengths

  Have LiDAR technology, financing capabilities, and scaled production experience.

  Weaknesses

  Their business mix is more mature and has higher automotive LiDAR exposure, and they are not pure-play humanoid robot 3D vision platforms.

  Comparison

  The two typically trade on price-to-earnings ratios, while Orbbec is mainly valued on price-to-sales because it is in the early stage of high-growth commercialization.

  Risks

  If they quickly redirect higher R&D investment and mass-production capabilities toward robot vision, they may compress Orbbec’s share, pricing, and margins.

Key data

• Rating and target priceOverweight; Rmb150The target date is December 2027, implying 38% potential upside versus the current price of Rmb109.02 on August 5, 2026.
• China humanoid robot vision hardware shareApproximately 95%Management estimate, reflecting the company’s current leading position in the domestic market.
• Global humanoid robot shipment forecastApproximately 150% compound growth rate from 2025 to 2030Under the base case, global shipments in 2030 are approximately 1.75 million units, with China contributing about 50%.
• Humanoid robot business revenue growthApproximately 35% compound growth rate from 2025 to 2030The revenue share of humanoid robot applications is expected to rise from approximately 5% in 2025 to 54% in 2028.
• 2026 sales guidanceRmb1.6 billion–2.0 billionThe range after management’s upward revision, with the midpoint corresponding to approximately 90% year-on-year growth.
• Average value per moduleApproximately Rmb2,000The specific amount depends on the vision solution; the number of modules per robot is expected to increase from 1–2 to at least 4.
• 3D vision value per unitApproximately Rmb3,000–5,000Vision and sensors together account for approximately 20% of a humanoid robot’s BOM, and 3D vision still has room to increase its share.
• Gross margin of humanoid robot applicationsExpected to remain above 50%Higher than most key hardware components, though competition and pricing pressure still need to be monitored.
• Financial forecastsFY25A–FY28E revenue growth of approximately 66.7%, 75.0%, 63.0%, and 60.2%, respectivelyCorresponding FY25A–FY28E net margins are approximately 13.6%, 19.2%, 22.9%, and 24.1%, reflecting scale effects.
• Valuation multiple23x FY27E forward price-to-sales ratioThe report believes the company should trade at the upper end of the comparable company valuation range, based on its scarce platform position, high market share, and growth potential beyond robotics.

Impact & implications

If humanoid robots achieve scaled shipments as forecast, Orbbec’s revenue elasticity will come from both growth in robot volumes and an increase in vision modules per unit, while a rising share of high-margin products is expected to drive margin expansion. The company’s high exposure to the robotics business makes it a highly sensitive proxy for the domestic humanoid robot industry trend, but also means its share price will continue to be significantly affected by industry news, OEM mass-production plans, changes in technology routes, and market risk appetite.

Risks

• New entrants and LiDAR manufacturers accelerating their entry into the humanoid robot vision market may lead to loss of design share and declines in single-module ASP.
• Progress in end-to-end models, monocular vision, or other software-based perception solutions may reduce demand for depth-vision hardware and the number of modules.
• A rising share of tactile, force, and other sensing methods may weaken the relative value of vision systems in robot architectures.
• Commercialization and shipment volume growth of humanoid robots slower than expected would affect revenue growth and the realization of a high valuation.
• If quality control, supply chain management, and working capital discipline are poorly executed during capacity expansion, scale effects may be weakened.
• Rising customer concentration may strengthen the bargaining power of leading OEMs and put pressure on selling prices and gross margin.
• The stock has high beta and significant volatility, and weakening industry sentiment or unstable earnings delivery may trigger valuation derating.
• The report’s key warning thresholds include domestic market share falling below 80% within three years, or gross margin falling below 40%.

What to watch

• 2026 sales guidance of Rmb1.6 billion–2.0 billion and quarterly order execution.
• Clear mass-production plans and capital activities of domestic humanoid robot OEMs in the second half of 2026.
• Progress in the Vietnam factory ramp-up, overseas customer introductions, and realization of overseas design capacity in 2027.
• Whether the revenue share of the humanoid robot business rises as forecast to 37% in 2027 and 54% in 2028.
• Changes in the number of vision modules per robot, single-module ASP, and 3D vision value per unit.
• New products, customer design wins, and mass-production progress from competitors such as RoboSense and Hesai.
• Whether the company can maintain a share of more than 80% in China’s humanoid robot vision market.
• Whether gross margins of the overall business and AIoT business can remain above the key levels of 40% and 50%.
• The impact of software vision, monocular solutions, VLA models, and multi-sensor fusion on demand for depth hardware.
• Whether operating cash flow, capital expenditure, quality control, and working capital match rapid expansion.